Immunocore Holdings plc (IMCR) Debt Components
- 2024-09-30: Long-term DebtUSD $438.69M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $6.25M; Long-Term Debt, Maturity, Year ThreeUSD $25.00M.
- 2024-06-30: Long-term DebtUSD $452.50M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $6.25M; Long-Term Debt, Maturity, Year ThreeUSD $25.00M.
- 2024-03-31: Long-term DebtUSD $452.50M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $6.25M; Long-Term Debt, Maturity, Year ThreeUSD $25.00M.
- 2024-02-02: Long-term DebtUSD $402.50M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
Immunocore Holdings plc Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Borrowings GBP |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $438.69M | $0.00 | $6.25M | $25.00M | $18.75M | $0.00 | $452.50M | (m) | (m) | (m) |
| 2024-06-30 | $452.50M | $0.00 | $6.25M | $25.00M | $18.75M | $0.00 | (m) | (m) | (m) | (m) |
| 2024-03-31 | $452.50M | $0.00 | $6.25M | $25.00M | $18.75M | $0.00 | (m) | (m) | (m) | (m) |
| 2024-02-02 | $402.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $0.00 | $0.00 | $6.25M | $25.00M | (m) | (m) | $18.75M | $50.00M | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 39.50M |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 37.23M |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 36.65M |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |